Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis
PFE
Statements (5)
- Bullish
Pfizer raised its guidance for the year
- Bullish
Pfizer raised its annual forecast citing momentum in newly launched and acquired products
- Bullish
Pfizer reported earnings that exceeded analyst estimates
- Bullish
Pfizer raises its 2026 forecast
- Neutral
Pfizer's net profit was driven by exceptional items.
More in this storyline
About Pfizer Inc
- Pfizer Inc. reported a profit drop in the third quarter of 2026
- and 1 more in the API
Grouped automatically. A story here may not belong, and others may be missing.